Click to Share
 

Drug Discovery Press Releases

Exclusive News
Topics Locations Industries Dates

By Neurolixis, Inc.
Neurolixis issued a new US patent for treatment of Fragile X syndrome with NLX-101

Page updated every 10 minutes


Like PRLog?
9K2K1K
Click to Share